本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Syros Pharmaceuticals, Inc.

0.0300
-0.0008-2.60%
成交量:14.94万
成交额:4,203.13
市值:80.50万
市盈率:-0.01
高:0.0300
开:0.0268
低:0.0257
收:0.0308
数据加载中...
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/06

重要事件披露

Form 8-K - Current report
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

重要事件披露

Form 8-K - Current report